High-Affinity Insulin Binding: Insulin Interacts with Two Receptor Ligand Binding Sites
Authors:
- 7 November 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 47 (48) , 12900-12909
Abstract
The interaction of insulin with its receptor is complex. Kinetic and equilibrium binding studies suggest coexistence of high- and low-affinity binding sites or negative cooperativity. These phenomena and high-affinity interactions are dependent on the dimeric structure of the receptor. Structure−function studies of insulin analogs suggest insulin has two receptor binding sites, implying a bivalent interaction with the receptor. Alanine scanning studies of the secreted recombinant receptor implicate the L1 domain and a C-terminal peptide of the receptor α subunit as components of one ligand binding site. Functional studies suggest that the first and second type III fibronectin repeats of the receptor contain a second ligand binding site. We have used structure-directed alanine scanning mutagenesis to identify determinants in these domains involved in ligand interactions. cDNAs encoding alanine mutants of the holo-receptor were transiently expressed in 293 cells, and the binding properties of the expressed receptor were determined. Alanine mutations of Lys484, Leu552, Asp591, Ile602, Lys616, Asp620, and Pro621 compromised affinities for insulin 2−5-fold. With the exception of Asp620, none of these mutations compromised the affinity of the recombinant secreted receptor for insulin, indicating that the perturbation of the interaction is at the site of mutation and not an indirect effect on the interaction with the binding site of the secreted receptor. These residues thus form part of a novel ligand binding site of the insulin receptor. Complementation experiments demonstrate that insulin interacts in trans with both receptor binding sites to generate high-affinity interactions.Keywords
This publication has 47 references indexed in Scilit:
- Alanine Scanning of a Putative Receptor Binding Surface of Insulin-like Growth Factor-IJournal of Biological Chemistry, 2008
- Activation of the Insulin Receptor by Insulin and a Synthetic Peptide Leads to Divergent Metabolic and Mitogenic Signaling and ResponsesJournal of Biological Chemistry, 2007
- Differential Activation of Insulin Receptor Substrates 1 and 2 by Insulin-Like Growth Factor-Activated Insulin ReceptorsMolecular and Cellular Biology, 2007
- Characterization of insulin/IGF hybrid receptors: contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced exon 11 sequence to ligand binding and receptor activationBiochemical Journal, 2007
- Characterization of a second ligand binding site of the insulin receptorBiochemical and Biophysical Research Communications, 2006
- Critical nodes in signalling pathways: insights into insulin actionNature Reviews Molecular Cell Biology, 2006
- Rescue of ligand binding of a mutant IGF-I receptor by complementationBiochemical and Biophysical Research Communications, 2005
- How Insulin Binds: the B-Chain α-Helix Contacts the L1 β-Helix of the Insulin ReceptorJournal of Molecular Biology, 2004
- Fusion of Insulin Receptor Ectodomains to Immunoglobulin Constant Domains Reproduces High-affinity Insulin Binding in VitroJournal of Biological Chemistry, 1996
- The nonclassical insulin binding of insulin receptors from rat liver is due to the presence of two interacting α-subunits in the receptor complexBiochemical and Biophysical Research Communications, 1986